Resultados de búsqueda - Yuxian He

Limitar resultados
  1. 1
    SARS Vaccine Development

    SARS Vaccine Development por Shibo Jiang, Yuxian He, Shuwen Liu

    Publicado 2005
    Enlace del recurso Enlace del recurso
    Revisão
    Agregar a favoritos
    Guardado en:
  2. 2
    SARS Vaccine Development

    SARS Vaccine Development por Shibo Jiang, Yuxian He, Shuwen Liu

    Publicado 2005
    Enlace del recurso Enlace del recurso
    Artigo
    Agregar a favoritos
    Guardado en:
  3. 3
    Inactivated SARS-CoV vaccine elicits high titers of spike protein-specific antibodies that block receptor binding and virus entry

    Inactivated SARS-CoV vaccine elicits high titers of spike protein-specific antibodies that block receptor binding and virus entry por Yuxian He, Yusen Zhou, Pamela Siddiqui, Shibo Jiang

    Publicado 2004
    Enlace del recurso
    Artigo
    Agregar a favoritos
    Guardado en:
  4. 4
    Antigenic and Immunogenic Characterization of Recombinant Baculovirus-Expressed Severe Acute Respiratory Syndrome Coronavirus Spike Protein: Implication for Vaccine Design

    Antigenic and Immunogenic Characterization of Recombinant Baculovirus-Expressed Severe Acute Respiratory Syndrome Coronavirus Spike Protein: Implication for Vaccine Design por Yuxian He, Jingjing Li, Susanne Heck, Sara Lustigman, Shibo Jiang

    Publicado 2006
    Enlace del recurso
    Artigo
    Agregar a favoritos
    Guardado en:
  5. 5
    Identification of Immunodominant Epitopes on the Membrane Protein of the Severe Acute Respiratory Syndrome-Associated Coronavirus

    Identification of Immunodominant Epitopes on the Membrane Protein of the Severe Acute Respiratory Syndrome-Associated Coronavirus por Yuxian He, Yusen Zhou, Pamela Siddiqui, Jinkui Niu, Shibo Jiang

    Publicado 2005
    Enlace del recurso
    Artigo
    Agregar a favoritos
    Guardado en:
  6. 6
    Design of a highly potent HIV-1 fusion inhibitor targeting the gp41 pocket

    Design of a highly potent HIV-1 fusion inhibitor targeting the gp41 pocket por Huihui Chong, Zonglin Qiu, Yang Su, Lingli Yang, Yuxian He

    Publicado 2014
    Enlace del recurso
    Artigo
    Agregar a favoritos
    Guardado en:
  7. 7
    Design of Potent Membrane Fusion Inhibitors against SARS-CoV-2, an Emerging Coronavirus with High Fusogenic Activity

    Design of Potent Membrane Fusion Inhibitors against SARS-CoV-2, an Emerging Coronavirus with High Fusogenic Activity por Yuanmei Zhu, Danwei Yu, Hongxia Yan, Huihui Chong, Yuxian He

    Publicado 2020
    Enlace del recurso
    Artigo
    Agregar a favoritos
    Guardado en:
  8. 8
    Identification of SARS-CoV RBD-targeting monoclonal antibodies with cross-reactive or neutralizing activity against SARS-CoV-2

    Identification of SARS-CoV RBD-targeting monoclonal antibodies with cross-reactive or neutralizing activity against SARS-CoV-2 por Wanbo Tai, Xiujuan Zhang, Yuxian He, Shibo Jiang, Lanying Du

    Publicado 2020
    Enlace del recurso
    Artigo
    Agregar a favoritos
    Guardado en:
  9. 9
    Mapping of Antigenic Sites on the Nucleocapsid Protein of the Severe Acute Respiratory Syndrome Coronavirus

    Mapping of Antigenic Sites on the Nucleocapsid Protein of the Severe Acute Respiratory Syndrome Coronavirus por Yuxian He, Yusen Zhou, Hao Wu, Zhihua Kou, Shuwen Liu, Shibo Jiang

    Publicado 2004
    Enlace del recurso
    Artigo
    Agregar a favoritos
    Guardado en:
  10. 10
    Design and Characterization of Cholesterylated Peptide HIV-1/2 Fusion Inhibitors with Extremely Potent and Long-Lasting Antiviral Activity

    Design and Characterization of Cholesterylated Peptide HIV-1/2 Fusion Inhibitors with Extremely Potent and Long-Lasting Antiviral Activity por Yuanmei Zhu, Huihui Chong, Danwei Yu, Yan Guo, Yusen Zhou, Yuxian He

    Publicado 2019
    Enlace del recurso
    Artigo
    Agregar a favoritos
    Guardado en:
  11. 11
    The spike protein of SARS-CoV — a target for vaccine and therapeutic development

    The spike protein of SARS-CoV — a target for vaccine and therapeutic development por Lanying Du, Yuxian He, Yusen Zhou, Shuwen Liu, Bo-Jian Zheng, Shibo Jiang

    Publicado 2009
    Enlace del recurso Enlace del recurso
    Revisão
    Agregar a favoritos
    Guardado en:
  12. 12
    N-Substituted Pyrrole Derivatives as Novel Human Immunodeficiency Virus Type 1 Entry Inhibitors That Interfere with the gp41 Six-Helix Bundle Formation and Block Virus Fusion

    N-Substituted Pyrrole Derivatives as Novel Human Immunodeficiency Virus Type 1 Entry Inhibitors That Interfere with the gp41 Six-Helix Bundle Formation and Block Virus Fusion por Shibo Jiang, Hong Lü, Shuwen Liu, Qian Zhao, Yuxian He, Asim K. Debnath

    Publicado 2004
    Enlace del recurso
    Artigo
    Agregar a favoritos
    Guardado en:
  13. 13
    Broad Antiviral Activity and Crystal Structure of HIV-1 Fusion Inhibitor Sifuvirtide

    Broad Antiviral Activity and Crystal Structure of HIV-1 Fusion Inhibitor Sifuvirtide por Xue Yao, Huihui Chong, Chao Zhang, S. Waltersperger, Meitian Wang, Sheng Cui, Yuxian He

    Publicado 2012
    Enlace del recurso
    Artigo
    Agregar a favoritos
    Guardado en:
  14. 14
    Identification of a critical neutralization determinant of severe acute respiratory syndrome (SARS)-associated coronavirus: importance for designing SARS vaccines

    Identification of a critical neutralization determinant of severe acute respiratory syndrome (SARS)-associated coronavirus: importance for designing SARS vaccines por Yuxian He, Qingyu Zhu, Shuwen Liu, Yusen Zhou, Yang Baoan, Jiaming Li, Shibo Jiang

    Publicado 2005
    Enlace del recurso
    Artigo
    Agregar a favoritos
    Guardado en:
  15. 15
    Biophysical Property and Broad Anti-HIV Activity of Albuvirtide, a 3-Maleimimidopropionic Acid-Modified Peptide Fusion Inhibitor

    Biophysical Property and Broad Anti-HIV Activity of Albuvirtide, a 3-Maleimimidopropionic Acid-Modified Peptide Fusion Inhibitor por Huihui Chong, Xue Yao, Chao Zhang, Lifeng Cai, Sheng Cui, Youchun Wang, Yuxian He

    Publicado 2012
    Enlace del recurso Enlace del recurso
    Artigo
    Agregar a favoritos
    Guardado en:
  16. 16
    Receptor-binding domain of SARS-CoV spike protein induces highly potent neutralizing antibodies: implication for developing subunit vaccine

    Receptor-binding domain of SARS-CoV spike protein induces highly potent neutralizing antibodies: implication for developing subunit vaccine por Yuxian He, Yusen Zhou, Shuwen Liu, Zhihua Kou, Wenhui Li, Michael Farzan, Shibo Jiang

    Publicado 2004
    Enlace del recurso
    Artigo
    Agregar a favoritos
    Guardado en:
  17. 17
    Potent and persistent antibody responses against the receptor-binding domain of SARS-CoV spike protein in recovered patients

    Potent and persistent antibody responses against the receptor-binding domain of SARS-CoV spike protein in recovered patients por Zhiliang Cao, Lifeng Liu, Lanying Du, Chao Zhang, Shibo Jiang, Taisheng Li, Yuxian He

    Publicado 2010
    Enlace del recurso Enlace del recurso
    Artigo
    Agregar a favoritos
    Guardado en:
  18. 18
    Identification of Immunodominant Sites on the Spike Protein of Severe Acute Respiratory Syndrome (SARS) Coronavirus: Implication for Developing SARS Diagnostics and Vaccines

    Identification of Immunodominant Sites on the Spike Protein of Severe Acute Respiratory Syndrome (SARS) Coronavirus: Implication for Developing SARS Diagnostics and Vaccines por Yuxian He, Yusen Zhou, Hao Wu, Baojun Luo, Jingming Chen, Wanbo Li, Shibo Jiang

    Publicado 2004
    Enlace del recurso
    Artigo
    Agregar a favoritos
    Guardado en:
  19. 19
    Design and characterization of novel SARS-CoV-2 fusion inhibitors with N-terminally extended HR2 peptides

    Design and characterization of novel SARS-CoV-2 fusion inhibitors with N-terminally extended HR2 peptides por Yue Hu, Yuanmei Zhu, Yanying Yu, Nian Liu, Xiaohui Ju, Qiang Ding, Yuxian He

    Publicado 2023
    Enlace del recurso
    Artigo
    Agregar a favoritos
    Guardado en:
  20. 20
    Receptor-binding domain of SARS-CoV spike protein induces long-term protective immunity in an animal model

    Receptor-binding domain of SARS-CoV spike protein induces long-term protective immunity in an animal model por Lanying Du, Guangyu Zhao, Yuxian He, Yan Guo, Bo‐Jian Zheng, Shibo Jiang, Yusen Zhou

    Publicado 2006
    Enlace del recurso
    Artigo
    Agregar a favoritos
    Guardado en:

Herramientas de búsqueda: